Accessibility refers to equitable delivery aimed at all who could benefit from a new TB vaccine for adults and adolescents. This includes defined implementation strategies, having delivery systems and sustainable financing strategies in place. This follows from the WHO global framework for country introduction of new adolescent and adult TB vaccines (https://www.who.int/publications/m/item/who-global-framework-to-prepare-for-country-introduction-of-new-tb-vaccines-for-adults-and-adolescents)
Accessibility
Country and target population prioritization
Evidence-based matrixing approach to identify priority countries and target populations through an iterative process, engaging a set of diverse stakeholders
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines
Our study provides crucial information for implementing novel TB vaccines in specific target groups and on country specific acceptability and feasibility. Key groups for vaccine implementation in these settings were identified, and should be included in clinical trials and implementation planning.
Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review
By synthesizing the existing body of knowledge, this review offers comprehensive insights into the current state of research on implementation of these TB adults and adolescent vaccines. Offering insights into key dimensions: (1) epidemiological impact, (2) costing, cost-effectiveness, and/or economic impact, (3) acceptability, and the (4) feasibility of implementation; this includes implementation strategies of target populations, and health system capabilities.
Conducting market analyses for new tuberculosis vaccines for adolescents and adults: A summary of one approach applied to M72/AS01E
A summary report of the methodology used in the MM Global Health Consulting (MMGH) market analysis and the high-level findings and recommendations.